Analysis of the Chemotherapy-Free Interval following Image-Guided Ablation in Sarcoma Patients.

In conclusion, ablation of sarcoma metastases can provide an extended systemic chemotherapy-free interval of greater than 1 year. Ablation of sarcoma metastases may improve patient quality of life by extending the chemotherapy-free interval. PMID: 32148436 [PubMed]

https://www.ncbi.nlm.nih.gov/pubmed/32148436?dopt=Abstract

Source: Sarcoma - March 11, 2020 Category: Cancer & Oncology Tags: Sarcoma Source Type: research